Hemogenyx Pharmaceuticals Share Discussion Threads

[purple11] 27/4/2020 12:08

#SWIMMING IN POUND NOTES

[purple11] 27/4/2020 11:54

just sold a second batch at 3.70

[netcurtains] 27/4/2020 11:46

lh: If you dont want the old one, I'll take it off your hands.

[lionheart69uk1] 27/4/2020 11:44

Just sold half my holding for 3.92p as I was getting twitchy. Meanwhile, would you do me a favour Dave and put in an order for a new Aston Martin with the profits earned from Hemo as their share price also needs a boost?

[purple11] 27/4/2020 11:23

davet at home swigging his little bottle of Babycham….

[purple11] 27/4/2020 11:04

watch and weep davet

[purple11] 27/4/2020 11:03

can it hit my previous sell price of 6.4!

[jibba jabber] 27/4/2020 11:03

Best start looking at the Lamborghini order now as the wait list is quite long.

[purple11] 27/4/2020 11:02

but has shukan banked the money?all paper profits that can vanish unless you hit the sell button.

[74tom] 27/4/2020 11:01

Real bid is at 3.66, nothing available to buy...pent up demand really building up now!

[purple11] 27/4/2020 11:01

the wally speaks

[tullynessle] 27/4/2020 10:54

Noting reports in the media that:

i. future immunity is not assured for those who have contracted Covid-19. and

ii. there is a risk that the current Covid-19 virus may mutate

iii. there does not appear to be a Covid-19 vaccine or drug to manage its symptoms
at this time, or in the near future.

IMO, it is imperative that over the short and longer term, the technology contemplated by Hemogenyx, and described in the paragraph at "Extract" below, is successful, (not only as applicable to Covid-19 but to potentially, "a host of viral pathogens"

It should be noted that it appears Hemogenyx's patented "ApbHC humanized mice" will be an integral component of HEMOs study.

I own shares in HEMO / DYOR


Extract:

"In addition, the study will aim to demonstrate how Hemogenyx's technology can be deployed rapidly in emergencies in order to discover human neutralizing antibodies against a host of viral pathogens, including what infectious disease experts in the bioprotection and biodefense sectors call "Disease X", meaning as-yet unknown viruses that may represent a similar or greater threat than the one presented by COVID-19."






Hemogenys - RNS

Hemogenyx Pharmaceuticals PLC COVID-19 Project Initiated
22/04/2020

Hemogenyx to use its advanced humanized mice to develop potential treatments for COVID-19.

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is deploying its groundbreaking research and technologies to develop potential treatments for COVID-19.

News Release continues.....

[dave4545] 27/4/2020 10:47

69

You'll find I make considerably more money than you in this game. I have 50k BRH at 7p still sitting in the account let alone the 8-11p ones

[dave4545] 27/4/2020 10:46

1 minute silence for all those get rich quick buck merchants who piled in at 2.3-2.5 on Thursday and sold for 1.92-2.1p Friday

[tullynessle] 27/4/2020 10:46

Noting reports in the media that:

i. future immunity is not assured for those who have contracted Covid-19. and

ii. there is a risk that the current Covid-19 virus may mutate

iii. there does not appear to be a Covid-19 vaccine or drug to manage its symptoms
at this time, or in the near future.

IMO, it is imperative that over the short and longer term, the technology contemplated by Hemogenyx, and described in the paragraph at "Extract" below, is successful, (not only as applicable to Covid-19 but to potentially, "a host of viral pathogens"

It should be noted that it appears Hemogenyx's patented "ApbHC humanized mice" will be an integral component of HEMOs study.

I own shares in HEMO / DYOR


Extract:

"In addition, the study will aim to demonstrate how Hemogenyx's technology can be deployed rapidly in emergencies in order to discover human neutralizing antibodies against a host of viral pathogens, including what infectious disease experts in the bioprotection and biodefense sectors call "Disease X", meaning as-yet unknown viruses that may represent a similar or greater threat than the one presented by COVID-19."






Hemogenys - RNS

Hemogenyx Pharmaceuticals PLC COVID-19 Project Initiated
22/04/2020

Hemogenyx to use its advanced humanized mice to develop potential treatments for COVID-19.

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is deploying its groundbreaking research and technologies to develop potential treatments for COVID-19.

News Release continues.....

[purple11] 27/4/2020 10:45

im going to sell some more at 4-4.50